Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, March 23, 2023
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
Wed, March 22, 2023
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
Corinne Jenkins Downgraded (ALT) to Hold and Decreased Target to $6 on, Mar 22nd, 2023
Corinne Jenkins of Goldman Sachs, Downgraded "Altimmune, Inc." (ALT) to Hold and Decreased Target from $20 to $6 on, Mar 22nd, 2023.
Corinne has made no other calls on ALT in the last 4 months.
There are 2 other peers that have a rating on ALT. Out of the 2 peers that are also analyzing ALT, 0 agree with Corinne's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Corinne
- Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $50 on, Thursday, March 9th, 2023
- Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Increased Target to $25 on, Wednesday, January 18th, 2023
